DARPA grants ASU up to $38.8 million to create epigenetic tool for fight against weapons of mass destruction

Arizona State University announced today that it has been selected by the U.S. Defense Advanced Research Projects Agency (DARPA) to build a field-deployable, point-of-care device that will determine in 30 minutes or less if a person has been exposed to weapons of mass destruction or their precursors. The DARPA award, worth up to $38.8 million over four years in phases and options, will build on the university’s growing capabilities in developing molecular diagnostics for applications in defense and human health.Continue reading

HTG Expands Data Analytics Capabilities for Customers with the Release of HTG EdgeSeq Reveal Data Analytics Software Version 1.2.0

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, announced the release of its HTG EdgeSeqTM Reveal data analytics software, version 1.2.0. HTG EdgeSeq Reveal is a powerful software product that can enable customers to streamline their analysis of samples processed on the HTG EdgeSeq platform.Continue reading